Achieve Life Sciences, Inc.

NasdaqCM:ACHV Stock Report

Market Cap: US$176.8m

Achieve Life Sciences Management

Management criteria checks 2/4

Achieve Life Sciences' CEO is Rick Stewart, appointed in Aug 2024, has a tenure of 1.67 years. total yearly compensation is $1.74M, comprised of 29.4% salary and 70.6% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth $761.06K. The average tenure of the management team and the board of directors is 1.4 years and 3.1 years respectively.

Key information

Rick Stewart

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage29.38%
CEO tenure1.7yrs
CEO ownership0.4%
Management average tenure1.4yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

Regulatory And Commercial Hurdles Will Test Smoking Cessation Catalyst Yet Long Term Potential Remains

Catalysts About Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company focused on bringing cytisinicline, a nicotine dependence treatment, to market for smoking and vaping cessation. What are the underlying business or industry changes driving this perspective?

Regulatory Tailwinds And Public Health Demand Will Support This Nicotine Cessation Opportunity

Catalysts About Achieve Life Sciences Achieve Life Sciences is a clinical stage biopharmaceutical company focused on developing cytisinicline as a treatment for nicotine dependence in smokers and vapers. What are the underlying business or industry changes driving this perspective?

FDA Priority Voucher And Smoking Cessation Tailwinds Will Transform This Undervalued Biotech Story

Catalysts About Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company focused on developing and commercializing cytisinicline as a treatment for nicotine dependence in smokers and people who vape. What are the underlying business or industry changes driving this perspective?

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy

Feb 04

Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Feb 15
Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Jul 01

Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Jan 27
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Oct 26
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

CEO Compensation Analysis

How has Rick Stewart's remuneration changed compared to Achieve Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$55m

Sep 30 2025n/an/a

-US$52m

Jun 30 2025n/an/a

-US$50m

Mar 31 2025n/an/a

-US$46m

Dec 31 2024US$2mUS$510k

-US$40m

Sep 30 2024n/an/a

-US$33m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$27m

Dec 31 2023US$1mUS$450k

-US$30m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$44m

Dec 31 2022US$1mUS$400k

-US$42m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$32m

Mar 31 2022n/an/a

-US$33m

Dec 31 2021US$1mUS$400k

-US$33m

Sep 30 2021n/an/a

-US$31m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$19m

Dec 31 2020US$1mUS$474k

-US$15m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$797kUS$500k

-US$16m

Compensation vs Market: Rick's total compensation ($USD1.74M) is about average for companies of similar size in the US market ($USD1.56M).

Compensation vs Earnings: Rick's compensation has increased whilst the company is unprofitable.

CEO

Rick Stewart (66 yo)

1.7yrs
Tenure
US$1,735,552
Compensation

Dr. Richard A. B. Stewart, also known as Rick, serves as President at Achieve Life Sciences, Inc. from December 2025. He had been an Executive Chairman at Achieve Life Sciences, Inc. since September 28, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Richard A. Stewart
President1.7yrsUS$1.74m0.43%
$ 761.1k
Mark Oki
Chief Financial Officer1.3yrsUS$1.41m0.24%
$ 424.8k
Craig Donnelly
Chief Operations Officerless than a yearno data0.098%
$ 173.9k
Jerry Wan
VP of Finance & Principal Accounting Officerno datano data0.061%
$ 108.5k
Erik Atkisson
Chief Legal Officerless than a yearno datano data
Jaime Xinos
Chief Commercial Officer9.3yrsno data0.14%
$ 247.1k
Mark Rubinstein
Chief Medical Officer1.5yrsno data0.074%
$ 131.5k
Nicole Jones
Vice President of Strategic Communications & Stakeholder Relationsno datano datano data
1.4yrs
Average Tenure
52yo
Average Age

Experienced Management: ACHV's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Richard A. Stewart
President9.3yrsUS$1.74m0.43%
$ 761.1k
Thomas King
Independent Chairman3.1yrsUS$154.50k0.59%
$ 1.0m
Stuart Duty
Independent Director3.1yrsUS$162.88k0%
$ 0
Kristen Slaoui
Independent Director1.3yrsno data0%
$ 0
Thomas Sellig
Independent Director3.1yrsUS$163.85k0%
$ 0
Bridget Martell
Independent Director5.1yrsUS$164.38k0%
$ 0
Nancy Phelan
Independent Director1.3yrsno data0%
$ 0
3.1yrs
Average Tenure
59yo
Average Age

Experienced Board: ACHV's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/10 07:40
End of Day Share Price 2026/04/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Achieve Life Sciences, Inc. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCG Capital
Gary NachmanCGS International
Jason ButlerCitizens JMP Securities, LLC